发明名称 |
COMBINATION THERAPY FOR COPD |
摘要 |
The invention concerns an aerosol formulation suitable for administering to COPD patients by means of a pressurized metered dose inhaler (pMDI), comprising glycopyrronium chloride in combination with formoterol. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium chloride and the formoterol components. Optionally the formulation further comprises beclometasone dipropionate. |
申请公布号 |
CA2785349(A1) |
申请公布日期 |
2011.06.30 |
申请号 |
CA20102785349 |
申请日期 |
2010.12.22 |
申请人 |
CHIESI FARMACEUTICI S.P.A. |
发明人 |
BONELLI, SAURO;ZAMBELLI, ENRICO;USBERTI, FRANCESCA |
分类号 |
A61K9/00;A61K31/167;A61K31/40;A61K45/06 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|